amifostine
information and resources from the National Cancer Institute
Ethyol
Accel. Approv. (clinical benefit not established) Reduction of platinum toxicity in non-small cell lung cancer
US Bioscience Mar 15 1996
Ethyol
To reduce post-radiation xerostomia for head and neck cancer where the radiation port includes a substantial portion of the parotid glands.
US Bioscience Jun 24 1999
Ethyol
To reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer
US Bioscience Dec 08 1995
|
|
|
|
news articles
Amifostine makes radiation more effective Mar 1, 2006
News-Medical.net, Doctors in Brazil have concluded that the drug amifostine eases many of the most common side effects associated with patients receiving radiation therapy to ...
Study: Amifostine boosts radiation therapy Mar 1, 2006
United Press International SAO PAULO, March 1 (UPI) -- The drug amifostine seems to lessen side effects from radiation therapy and makes cancer more susceptible to radiation. ...
Amifostine Reduces Radiotherapy Side Effects Mar 8, 2006
Cancerpage.com, NEW YORK MAR 07, 2006 (Reuters Health) - Amifostine reduces the side effects of radiation therapy and increases complete response rates without protecting ...
Subcutaneous Amifostine Feasible During Radiotherapy for Head and ... Mar 1, 2006
Cancerpage.com, NEW YORK FEB 28, 2006 (Reuters Health) - The use of subcutaneous amifostine to reduce the toxic effects of radiation therapy and chemotherapy is feasible in ...
Drug Improves Radiation Side Effects Mar 1, 2006
Ivanhoe, ...(Ivanhoe Newswire) -- A new study reveals the drug amifostine (Ethyol) may ease common side effects associated with radiation therapy while making the cancer ...
Ethyol Benefits Cancer Patients Undergoing Radiotherapy Mar 3, 2006
MedPage Today, SAO PAOLO, Brazil, March 3 - A systematic review and meta-analysis of Ethyol (amifostine) found that the agent significantly reduced many side effects of ...
In vivo Evaluation of Radioprotection by the Fullerene CD60_DF1 ... Nov 19, 2005
Medical News Today (press release), ...effects. Although one such drug, Amifostine, is now on the market, it carries toxicities of its own which has limited its use. Now ...
Nanotech May Also Minimize Chemo Damage Dec 2, 2005
ExtremeNano, There is only one drug on the market to protect normal tissue from the side effects of radiation and chemotherapy, Amifostine. Researchers ...
Fullerenes can help fend off damage to normal tissue from ... Nov 28, 2005
News-Medical.net, Only one drug, Amifostine, has been approved to date by the federal Food and Drug Administration, to help protect normal tissue from the side effects of ...
Nano World: Nano-based antiradiation drug Nov 29, 2005
United Press International To date, the FDA has approved just one drug, amifostine, to help protect normal tissue from the side effects of radiation and chemotherapy. ...
Nanoparticle may Reduce Radiation Side Effects Nov 20, 2005
Ivanhoe, ...or immediately after exposure to X-rays, it reduced organ damage by one-half to two-thirds, which is as good as the level of protection given by Amifostine. ...
Ethyol® Decreases Xerostomia Without Increasing Recurrences ... Nov 28, 2005
Cancer Consultants (press release), An international randomized trial has determined that Ethyol (amifostine) protects against xerostomia while not affecting long-term outcomes in patients with ...
Older Women Who Receive Pelvic Radiation at Risk for Pelvic ... Nov 22, 2005
SeniorJournal.com, ...authors conclude. Editor’s Note: Dr. Small is on the speakers bureau for MedImmune, the company that manufactures amifostine.
|
|
